These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 26997031

  • 21. Lower alloimmunization rates in pediatric sickle cell patients on chronic erythrocytapheresis compared to chronic simple transfusions.
    Wahl SK, Garcia A, Hagar W, Gildengorin G, Quirolo K, Vichinsky E.
    Transfusion; 2012 Dec; 52(12):2671-6. PubMed ID: 22519830
    [Abstract] [Full Text] [Related]

  • 22. Deferasirox for iron chelation in multitransfused children with sickle cell disease; long-term experience in the East London clinical haemoglobinopathy network.
    Tsouana E, Kaya B, Gadong N, Hemmaway C, Newell H, Simmons A, Whitmarsh S, Telfer P.
    Eur J Haematol; 2015 Apr; 94(4):336-42. PubMed ID: 25138173
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Iron overload in sickle cell anemia : a study of 94 patients].
    Hafsia R, Belakhal F, Ben Salah N, Gouider E, Elborgi W.
    Tunis Med; 2011 Jun; 89(6):548-52. PubMed ID: 21681718
    [Abstract] [Full Text] [Related]

  • 26. Comparison of serial serum ferritin measurements and liver iron concentration assessed by MRI in adult transfused patients with sickle cell disease.
    Tsitsikas DA, Nzouakou R, Ameen V, Sirigireddy B, Amos RJ.
    Eur J Haematol; 2014 Feb; 92(2):164-7. PubMed ID: 24175986
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Red blood cell exchange in patients with sickle cell disease-indications and management: a review and consensus report by the therapeutic apheresis subsection of the AABB.
    Biller E, Zhao Y, Berg M, Boggio L, Capocelli KE, Fang DC, Koepsell S, Music-Aplenc L, Pham HP, Treml A, Weiss J, Wool G, Baron BW.
    Transfusion; 2018 Aug; 58(8):1965-1972. PubMed ID: 30198607
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Study of gonadal hormones in Egyptian female children with sickle cell anemia in correlation with iron overload: Single center study.
    Hagag AA, El-Farargy MS, Elrefaey S, Abo El-enein AM.
    Hematol Oncol Stem Cell Ther; 2016 Mar; 9(1):1-7. PubMed ID: 26684919
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Ferritin and LIC: predicting liver injury in children with sickle cell.
    Smith E, Lebensburger J, Hilliard L, Kelly D, Fineberg N, Bai S, Howard T.
    J Pediatr Gastroenterol Nutr; 2014 Mar; 58(3):387-90. PubMed ID: 24553473
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Iron Chelators, Such as Deferasirox, When Combined With Hydroxyurea, Provide an Additional Benefit of Iron Chelation in Patients Receiving Chronic Transfusion Therapy.
    Manganas K, Delicou S, Xydaki A, Koskinas J.
    Hemoglobin; 2022 Mar; 46(2):114-117. PubMed ID: 36069257
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Feasibility and efficacy of chronic transfusion for stroke prevention in children with sickle cell disease.
    Mirre E, Brousse V, Berteloot L, Lambot-Juhan K, Verlhac S, Boulat C, Dumont MD, Lenoir G, de Montalembert M.
    Eur J Haematol; 2010 Mar; 84(3):259-65. PubMed ID: 19912310
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Pain and other non-neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: results from the SWiTCH clinical trial.
    Alvarez O, Yovetich NA, Scott JP, Owen W, Miller ST, Schultz W, Lockhart A, Aygun B, Flanagan J, Bonner M, Mueller BU, Ware RE, Investigators of the Stroke With Transfusions Changing to Hydroxyurea Clinical Trial (SWiTCH).
    Am J Hematol; 2013 Nov; 88(11):932-8. PubMed ID: 23861242
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.